[HTML][HTML] The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment

X Chen, M Cao, P Wang, S Chu, M Li, P Hou… - Frontiers in …, 2022 - frontiersin.org
Tripartite motif containing-21 (TRIM21), an E3 ubiquitin ligase, was initially found to be
involved in antiviral responses and autoimmune diseases. Recently studies have reported …

Development of pyrolo [2, 3-c] pyrazole, pyrolo [2, 3-d] pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity …

EM Azmy, M Hagras, MA Ewida, AS Doghish… - Bioorganic …, 2023 - Elsevier
Inhibiting the CDK2/cyclin A2 enzyme has been validated in multiple clinical manifestations
related to multiple types of cancer. Herein, novel series of pyrolo [2, 3-c] pyrazole, pyrolo [2 …

[HTML][HTML] CDK4/6 inhibitors in pancreatobiliary cancers: opportunities and challenges

T Arsenijevic, K Coulonval, E Raspé, A Demols… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatobiliary cancers are a group of malignancies affecting the
pancreas and biliary tract and are among the cancers with the lowest survival rate. Current …

[HTML][HTML] Machine learning-based virtual screening and molecular simulation approaches identified novel potential inhibitors for cancer therapy

M Shahab, G Zheng, A Khan, D Wei, AS Novikov - Biomedicines, 2023 - mdpi.com
Cyclin-dependent kinase 2 (CDK2) is a promising target for cancer treatment, developing
new effective CDK2 inhibitors is of great significance in anticancer therapy. The involvement …

TRIM21‐promoted FSP1 plasma membrane translocation confers ferroptosis resistance in human cancers

J Gong, Y Liu, W Wang, R He, Q Xia, L Chen… - Advanced …, 2023 - Wiley Online Library
Ferroptosis, an iron‐dependent form of regulated cell death driven by excessive
accumulation of lipid peroxides, has become a promising strategy in cancer treatment …

[HTML][HTML] Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding

EB Faber, L Sun, J Tang, E Roberts… - Nature …, 2023 - nature.com
Compared to most ATP-site kinase inhibitors, small molecules that target an allosteric pocket
have the potential for improved selectivity due to the often observed lower structural …

[HTML][HTML] DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma

Y Liu, Y Sun, J Yang, D Wu, S Yu, J Liu, T Hu, J Luo… - Molecular Cancer, 2024 - Springer
Background The faithful maintenance of DNA methylation homeostasis indispensably
requires DNA methyltransferase 1 (DNMT1) in cancer progression. We previously identified …

Screening through lead optimization of high affinity, allosteric cyclin-dependent kinase 2 (CDK2) inhibitors as male contraceptives that reduce sperm counts in mice

EB Faber, N Wang, K John, L Sun… - Journal of medicinal …, 2023 - ACS Publications
Although cyclin-dependent kinase 2 (CDK2) is a validated target for both cancer and
contraception, developing a CDK2 inhibitor with exquisite selectivity has been challenging …

[HTML][HTML] Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer

X Wang, W Shi, X Wang, JJ Lu, P He, H Zhang… - Cell Death …, 2023 - nature.com
Though palbociclib, a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor has been
approved for treating breast cancer, two major clinical challenges remain:(i) Triple-negative …

Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach

A Sahu, M Gaur, NC Mahanandia, E Subudhi… - Computers in Biology …, 2023 - Elsevier
Monkeypox virus (mpox virus) outbreak has rapidly spread to 82 non-endemic countries.
Although it primarily causes skin lesions, secondary complications and high mortality (1 …